biotin has been researched along with idrabiotaparinux in 16 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (idrabiotaparinux) | Trials (idrabiotaparinux) | Recent Studies (post-2010) (idrabiotaparinux) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 16 | 5 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eikelboom, J; O'Donnell, M; Sobieraj-Teague, M | 1 |
| Harenberg, J | 1 |
| Boëlle, E; Cortez, P; Destors, JM; Paty, I; Sanderink, G; Trellu, M | 1 |
| Weitz, JI | 1 |
| Eikelboom, JW; Weitz, JI | 1 |
| Büller, HR; Gallus, AS; Pillion, G; Prins, MH; Raskob, GE | 1 |
| Boëlle, E; Cheng, S; Cortez, P; Donat, F; Fau, JB; Paty, I; Sanderink, GJ; Trellu, M | 1 |
| Nieto Rodríguez, JA | 1 |
| Dalla Valle, F; Pesavento, R; Piovella, C; Prandoni, P; Tormene, D | 1 |
| Li, D; Li, X; Pavithra, S; Song, Y | 1 |
| Buller, HR; Halperin, J; Hankey, GJ; Pillion, G; Prins, MH; Raskob, GE | 1 |
| Greaves, M | 1 |
| Driguez, PA; Potier, P; Trouilleux, P | 1 |
| Reitsma, PH; Rosendaal, FR | 1 |
| Brandao, GM; Junqueira, DR; Rollo, HA; Sobreira, ML | 1 |
8 review(s) available for biotin and idrabiotaparinux
| Article | Year |
|---|---|
New anticoagulants for atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Benzamides; Benzimidazoles; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Vitamin K | 2009 |
Development of idraparinux and idrabiotaparinux for anticoagulant therapy.
Topics: Animals; Anticoagulants; Antithrombin III; Atrial Fibrillation; Avidin; Biotin; Carbohydrate Conformation; Carbohydrate Sequence; Drug Design; Drug Evaluation, Preclinical; Fondaparinux; Hemorrhage; Heparin Antagonists; Humans; Molecular Sequence Data; Molecular Structure; Oligosaccharides; Polysaccharides; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Thrombosis; Treatment Outcome | 2009 |
Potential of new anticoagulants in patients with cancer.
Topics: Anticoagulants; Benzimidazoles; Biotin; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Neoplasms; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombosis | 2010 |
[New approaches in the treatment of deep vein thrombosis].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis | 2012 |
New anticoagulants for the treatment of venous thromboembolism.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; Biotin; Dabigatran; Humans; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Thiazoles; Venous Thromboembolism; Vitamin K | 2013 |
Idraparinux or idrabiotaparinux for long-term venous thromboembolism treatment: a systematic review and meta-analysis of randomized controlled trials.
Topics: Biotin; Humans; Oligosaccharides; Randomized Controlled Trials as Topic; Venous Thromboembolism | 2013 |
Synthetic oligosaccharides as active pharmaceutical ingredients: lessons learned from the full synthesis of one heparin derivative on a large scale.
Topics: Biotin; Fondaparinux; Heparin; Molecular Structure; Oligosaccharides; Polysaccharides; Structure-Activity Relationship | 2014 |
Pentasaccharides for the treatment of deep vein thrombosis.
Topics: Anticoagulants; Biotin; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Oligosaccharides; Polysaccharides; Randomized Controlled Trials as Topic; Recurrence; Time Factors; Venous Thrombosis | 2017 |
5 trial(s) available for biotin and idrabiotaparinux
| Article | Year |
|---|---|
Reversibility of the anti-FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion.
Topics: Adolescent; Adult; Anticoagulants; Avidin; Biotin; Coagulants; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lower Extremity; Male; Oligosaccharides; Prospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Venous Thrombosis; Young Adult | 2010 |
Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis.
Topics: Adult; Aged; Anticoagulants; Biotin; Blood Coagulation; Double-Blind Method; Drug Administration Schedule; Europe; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Oligosaccharides; Recurrence; Risk Assessment; Time Factors; Treatment Outcome; United States; Venous Thrombosis | 2011 |
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Biotin; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Factor X; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Oligosaccharides; Pulmonary Embolism; Warfarin | 2012 |
Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Area Under Curve; Biotin; Factor Xa; Factor Xa Inhibitors; Humans; Male; Middle Aged; Oligosaccharides; Therapeutic Equivalency; Venous Thrombosis; Young Adult | 2013 |
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Biotin; Double-Blind Method; Drug Administration Schedule; Early Termination of Clinical Trials; Electrocardiography; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Oligosaccharides; Predictive Value of Tests; Risk Factors; Stroke; Thromboembolism; Time Factors; Treatment Outcome; Vitamin K; Warfarin | 2014 |
3 other study(ies) available for biotin and idrabiotaparinux
| Article | Year |
|---|---|
Idrabiotaparinux treatment for venous thromboembolism.
Topics: Anticoagulants; Biotin; Enoxaparin; Factor X; Female; Humans; Male; Oligosaccharides; Pulmonary Embolism; Warfarin | 2012 |
Clinical trials and tribulations.
Topics: Anticoagulants; Atrial Fibrillation; Biotin; Factor Xa Inhibitors; Female; Humans; Male; Oligosaccharides; Stroke; Thromboembolism; Vitamin K; Warfarin | 2014 |
Terminated.
Topics: Anticoagulants; Atrial Fibrillation; Biotin; Factor Xa Inhibitors; Female; Humans; Male; Oligosaccharides; Stroke; Thromboembolism; Vitamin K; Warfarin | 2014 |